thought call
lacklust perform top-lin ep vs street coupl
lower top-lin guidancefollow alreadi decreas guidanc
evok investor concern regard current pipelin abil suffici
off-set expect headwind face franchis next year view today result
underscor pfe need expand portfolio forecast revenu compound-annual-growth-rate
believ larger-scal extern growth asset i/o would
repres impact approach restor investor confid move forward
manag reiter perceiv modest bd strategi
reorgan chang ceo effect unlik shift pfe
 approach near-termw think potenti spin-off consum would provid
even stronger cash posit would character lower-
cost environ recent week nbi month beyond pipelin
current price paradigm remain top mind investor light recent
administr propos continu believ presid blueprint littl
impact pharma sectorthough delay price hike may view unfavor
investor clariti januari given perceiv non-
aggress bd approach pfe long-term growth strategi could remain overhang
remaind support equal weight rate pt
near-term pipelin event point sever near-term pipelin event
high interest investor tafamidi upcom file us eu
addit ph tanezumab data includ long-term safeti pdufa
lorlatinib novemb glasdegib decemb decis consum ye
model chang given perform updat guidanc made
adjust forecast chang non-gaap ep estim move
revenu figur
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
larg captur upsid key product
prevnar ibranc xtandi absent meaning
busi development/ acquisit see littl
upsid current revenu earn trend
better expect uptak prevnar ibranc
xtandi offset price pressur essenti
coupl pipelin success oncolog
success deploy capit toward could
result upsid forecast
faster eros essenti due price
pressur along lower growth innov could
result weaker top line growth failur deploy
capit pipelin asset could cloud
long-term outlook result share stay
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
made chang forecast beyond given perform
updat guidance/commentari provid call figur detail
million except per share itemspriorcurr chg amort incom attribut common item net ep ep outstand outstand analysispriorcurr chgchg bp gross changepriorcurr chgchg incom incom million except per share itemspriorcurr chg amort incom attribut common item net ep ep outstand outstand analysispriorcurr chgchg bp gross changepriorcurr chgchg incom incom barclay inc
geoff meacham ph herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
